Background Although several meta‐analyses have examined the effects of off‐label
underdosing of nonvitamin K antagonist oral anticoagulants (NOACs) compared with their …

Our study aims to develop an effective integrated machine learning (ML) scheme to predict
vascular events and bleeding in patients with nonvalvular atrial fibrillation taking dabigatran …

Aim Polypharmacy in multimorbid older patients with atrial fibrillation (AF) is a risk factor for
potentially inappropriate prescribing (PIP). We aimed to systematically assess the evidence …

Introduction Per-label dosing of direct oral anticoagulants (DOACs) is important for the
prevention of stroke and systemic embolism among patients with non-valvular atrial …

Important sex differences exist in the epidemiology and outcomes of atrial fibrillation (AF),
the most common sustained arrhythmia encountered in clinical practice. 1 Although the …

Introduction: This study aimed to investigate the association between polymorphisms in
fibrinogen genes and bleeding risk in patients receiving direct oral anticoagulants (DOACs) …

Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts
online as soon as possible after acceptance. Accepted manuscripts have been peer …

Clinically-driven dose reduction of direct oral anticoagulants in individuals with atrial
fibrillation is prevalent worldwide. However, a paucity of evidence to tailor dose selection …

Zusammenfassung Auf einen Blick Trend Die Gesamtverordnungen der
Thrombozytenaggregationshemmer sind 2022 gegenüber dem Vorjahr gering gesunken …

抄録 非弁膜症性心房細動 (NVAF) において, 左心耳血栓は心原性脳梗塞の最大要因である.
直接経口抗凝固薬 (DOAC) は, ワルファリンに比較して, 非劣性または優越性な全身塞栓予防効果 …